LT3386997T - Monomaleimidu funkcionalizuoti platinos junginiai, skirti vėžio terapijai - Google Patents
Monomaleimidu funkcionalizuoti platinos junginiai, skirti vėžio terapijaiInfo
- Publication number
- LT3386997T LT3386997T LTEPPCT/EP2016/080453T LT16080453T LT3386997T LT 3386997 T LT3386997 T LT 3386997T LT 16080453 T LT16080453 T LT 16080453T LT 3386997 T LT3386997 T LT 3386997T
- Authority
- LT
- Lithuania
- Prior art keywords
- monomaleimide
- cancer therapy
- platinum compounds
- functionalized platinum
- functionalized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15198739 | 2015-12-09 | ||
| PCT/EP2016/080453 WO2017097986A1 (en) | 2015-12-09 | 2016-12-09 | Monomaleimide-functionalized platinum compounds for cancer therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3386997T true LT3386997T (lt) | 2021-12-10 |
Family
ID=54849106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/EP2016/080453T LT3386997T (lt) | 2015-12-09 | 2016-12-09 | Monomaleimidu funkcionalizuoti platinos junginiai, skirti vėžio terapijai |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US10723748B2 (lt) |
| EP (1) | EP3386997B1 (lt) |
| JP (1) | JP6867652B2 (lt) |
| CN (1) | CN108368143B (lt) |
| AU (1) | AU2016367306B2 (lt) |
| CA (1) | CA3004630A1 (lt) |
| CY (1) | CY1124529T1 (lt) |
| DK (1) | DK3386997T3 (lt) |
| ES (1) | ES2898704T3 (lt) |
| HR (1) | HRP20211466T1 (lt) |
| HU (1) | HUE056897T2 (lt) |
| IL (1) | IL259864B (lt) |
| LT (1) | LT3386997T (lt) |
| MX (1) | MX2018006953A (lt) |
| PL (1) | PL3386997T3 (lt) |
| PT (1) | PT3386997T (lt) |
| RS (1) | RS62412B1 (lt) |
| SG (1) | SG11201804885TA (lt) |
| SI (1) | SI3386997T1 (lt) |
| WO (1) | WO2017097986A1 (lt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015200250A1 (en) * | 2014-06-23 | 2015-12-30 | Blend Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
| TWI808055B (zh) | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| TWI794171B (zh) | 2016-05-11 | 2023-03-01 | 美商滬亞生物國際有限公司 | Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療 |
| CN109171001A (zh) * | 2018-09-14 | 2019-01-11 | 上海烟草集团有限责任公司 | 草酸钠在降低卷烟烟气中TSNAs释放量中的应用 |
| US20230339997A1 (en) * | 2020-09-11 | 2023-10-26 | Shanghai Haiju Biological Technology Co., Ltd. | Class of platinum compounds for treating cancer, and method for preparation thereof |
| CN114539320A (zh) * | 2020-11-25 | 2022-05-27 | 北京大学 | 辐射激活的四价铂配合物及其用途 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| CH605550A5 (lt) | 1972-06-08 | 1978-09-29 | Research Corp | |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| ATE12348T1 (de) | 1980-11-10 | 1985-04-15 | Gersonde Klaus Prof Dr | Verfahren zur herstellung von lipid-vesikeln durch ultraschallbehandlung, anwendung des verfahrens und vorrichtung zur durchfuehrung des verfahrens. |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| DE3374837D1 (en) | 1982-02-17 | 1988-01-21 | Ciba Geigy Ag | Lipids in the aqueous phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| JPS607934A (ja) | 1983-06-29 | 1985-01-16 | Dai Ichi Seiyaku Co Ltd | リポソ−ムの製造方法 |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| EP0350973B1 (de) | 1983-09-26 | 1997-11-05 | Udo Dr. Ehrenfeld | Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr |
| US4615885A (en) | 1983-11-01 | 1986-10-07 | Terumo Kabushiki Kaisha | Pharmaceutical composition containing urokinase |
| CS269719B1 (en) | 1986-12-29 | 1990-05-14 | Kiss Frantisek | Platinum cytostatic |
| US6051256A (en) | 1994-03-07 | 2000-04-18 | Inhale Therapeutic Systems | Dispersible macromolecule compositions and methods for their preparation and use |
| DE19636889A1 (de) | 1996-09-11 | 1998-03-12 | Felix Dr Kratz | Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel |
| KR100572171B1 (ko) | 1997-09-29 | 2006-04-19 | 넥타르 테라퓨틱스 | 투여량 계측 흡입기용 안정화 제제 |
| EP1071752B1 (en) | 1998-04-21 | 2003-07-09 | Micromet AG | CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF |
| DE19926154A1 (de) | 1999-06-09 | 2000-12-14 | Ktb Tumorforschungs Gmbh | Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung |
| AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
| PT1280520E (pt) | 2000-05-10 | 2014-12-16 | Novartis Ag | Pós à base de fosfolípidos para administração de fármacos |
| SI1458360T1 (sl) | 2001-12-19 | 2011-08-31 | Novartis Ag | Pulmonalno dajanje aminoglikozidov |
| DE10314780A1 (de) | 2003-03-19 | 2004-09-30 | Ktb Tumorforschungsgesellschaft Mbh | Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden |
| JP2006521300A (ja) | 2003-03-31 | 2006-09-21 | プリヴァ−ラケマ，エー．エス． | 活性物質として白金錯体を含有する医薬組成物およびその製造方法 |
| CZ296169B6 (cs) | 2004-09-08 | 2006-01-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro rektální nebo vaginální podání, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
| CZ296459B6 (cs) | 2004-09-14 | 2006-03-15 | Pliva-Lachema A. S. | Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo |
| US20060205810A1 (en) | 2004-11-24 | 2006-09-14 | Schering Corporation | Platinum therapeutic combinations |
| CZ300424B6 (cs) | 2006-06-20 | 2009-05-13 | Pliva - Lachema A. S. | Farmaceutická kompozice pro perorální podání |
| CZ300590B6 (cs) | 2006-06-20 | 2009-06-24 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
| CZ300120B6 (cs) | 2006-06-20 | 2009-02-11 | Pliva - Lachema A. S. | Farmaceutická kompozice pro injekcní podání |
| EP2793585A4 (en) | 2011-12-05 | 2015-12-09 | Igenica Biotherapeutics Inc | Antibody-Agent Conjugates and Related Compounds, Compositions and Methods |
| KR102057356B1 (ko) * | 2012-02-27 | 2019-12-18 | 아뮤닉스 파마슈티컬스, 인크. | Ｘｔｅｎ 콘주게이트 조성물 및 그의 제조 방법 |
| EP3055317B1 (en) * | 2013-10-08 | 2018-01-31 | Atlas Genetics Limited | Labelling compounds and their use in assays |
| EP3089745A4 (en) | 2013-12-31 | 2017-05-17 | Placon Therapeutics, Inc. | Compounds, compositions, and methods for the treatment of cancers |
| WO2015200250A1 (en) * | 2014-06-23 | 2015-12-30 | Blend Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
| EP3313393A4 (en) | 2015-06-23 | 2019-01-09 | Placon Therapeutics, Inc. | PLATINUM COMPOUNDS, COMPOSITIONS, AND USES THEREOF |
| WO2016209918A1 (en) | 2015-06-23 | 2016-12-29 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
| US10624975B2 (en) | 2015-06-29 | 2020-04-21 | Case Western Reserve University | Anticancer drug-containing plant virus particles |
| NZ739830A (en) | 2015-07-12 | 2021-12-24 | Hangzhou Dac Biotech Co Ltd | Bridge linkers for conjugation of cell-binding molecules |
| JP7043425B2 (ja) | 2016-06-06 | 2022-03-29 | ジェネンテック， インコーポレイテッド | シルベストロール抗体－薬物コンジュゲート及び使用方法 |
| WO2018009811A1 (en) | 2016-07-08 | 2018-01-11 | Genentech, Inc. | Use of human epididymis protein 4 (he4) for assessing responsiveness of muc 16-positive cancer treatment |
| WO2018026742A1 (en) | 2016-08-01 | 2018-02-08 | Askgene Pharma Inc. | Novel antibody-albumin-drug conjugates (aadc) and methods for using them |
| CN108164512B (zh) | 2017-12-27 | 2021-05-25 | 沈阳药科大学 | 一类具有生物粘附作用的马来酰亚胺型前药及其在口服药物传递中的应用 |
| CN108187063B (zh) | 2018-01-09 | 2020-09-08 | 沈阳药科大学 | 白蛋白结合型抗肿瘤药-马来酰亚胺分子前药 |
-
2016
- 2016-12-09 CN CN201680072428.4A patent/CN108368143B/zh active Active
- 2016-12-09 RS RS20211187A patent/RS62412B1/sr unknown
- 2016-12-09 IL IL259864A patent/IL259864B/en unknown
- 2016-12-09 HR HRP20211466TT patent/HRP20211466T1/hr unknown
- 2016-12-09 AU AU2016367306A patent/AU2016367306B2/en active Active
- 2016-12-09 JP JP2018529981A patent/JP6867652B2/ja active Active
- 2016-12-09 WO PCT/EP2016/080453 patent/WO2017097986A1/en active Application Filing
- 2016-12-09 PL PL16822917T patent/PL3386997T3/pl unknown
- 2016-12-09 PT PT16822917T patent/PT3386997T/pt unknown
- 2016-12-09 CA CA3004630A patent/CA3004630A1/en active Pending
- 2016-12-09 HU HUE16822917A patent/HUE056897T2/hu unknown
- 2016-12-09 US US16/060,559 patent/US10723748B2/en active Active
- 2016-12-09 SI SI201631342T patent/SI3386997T1/sl unknown
- 2016-12-09 MX MX2018006953A patent/MX2018006953A/es active IP Right Grant
- 2016-12-09 EP EP16822917.7A patent/EP3386997B1/en active Active
- 2016-12-09 SG SG11201804885TA patent/SG11201804885TA/en unknown
- 2016-12-09 DK DK16822917.7T patent/DK3386997T3/da active
- 2016-12-09 ES ES16822917T patent/ES2898704T3/es active Active
- 2016-12-09 LT LTEPPCT/EP2016/080453T patent/LT3386997T/lt unknown
-
2020
- 2020-06-17 US US16/904,528 patent/US11572379B2/en active Active
-
2021
- 2021-09-27 CY CY20211100840T patent/CY1124529T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US10723748B2 (en) | 2020-07-28 |
| ES2898704T3 (es) | 2022-03-08 |
| CN108368143A (zh) | 2018-08-03 |
| US20180354979A1 (en) | 2018-12-13 |
| SG11201804885TA (en) | 2018-07-30 |
| SI3386997T1 (sl) | 2021-11-30 |
| US20210002313A1 (en) | 2021-01-07 |
| WO2017097986A1 (en) | 2017-06-15 |
| DK3386997T3 (da) | 2021-09-20 |
| AU2016367306A1 (en) | 2018-06-14 |
| CA3004630A1 (en) | 2017-06-15 |
| EP3386997B1 (en) | 2021-06-30 |
| CY1124529T1 (el) | 2022-07-22 |
| PT3386997T (pt) | 2021-11-04 |
| HRP20211466T1 (hr) | 2021-12-24 |
| RS62412B1 (sr) | 2021-10-29 |
| US11572379B2 (en) | 2023-02-07 |
| MX2018006953A (es) | 2019-05-16 |
| HUE056897T2 (hu) | 2022-03-28 |
| JP6867652B2 (ja) | 2021-05-12 |
| EP3386997A1 (en) | 2018-10-17 |
| JP2018538292A (ja) | 2018-12-27 |
| IL259864B (en) | 2022-07-01 |
| IL259864A (en) | 2018-07-31 |
| AU2016367306B2 (en) | 2021-04-22 |
| PL3386997T3 (pl) | 2021-12-13 |
| CN108368143B (zh) | 2022-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1247202A1 (zh) | 用於治療癌症的化合物 | |
| IL254705B (en) | Combined treatment for cancer | |
| ZA201702382B (en) | Combination therapy for cancer | |
| SG10201913631TA (en) | Rna for cancer therapy | |
| EP3148536C0 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| HK1231381A1 (zh) | 癌症組合療法 | |
| IL259864A (en) | Monomaleimide-functionalized platinum compounds for cancer therapy | |
| IL246761A0 (en) | Combined cancer treatment | |
| ZA201701450B (en) | Small molecule inhibitors for cancer therapy | |
| GB201519734D0 (en) | Cancer therapy | |
| HK1254687A1 (zh) | 用於癌症的聯合療法 | |
| HK1259615A1 (zh) | 谷氨酸-高z元素化合物治療癌症 | |
| HRP20210383T8 (hr) | Kombinirana terapija za rak | |
| GB201511609D0 (en) | Cancer therapy | |
| GB201511121D0 (en) | Cancer therapy | |
| GB201511120D0 (en) | Cancer therapy | |
| GB201417819D0 (en) | Agents for cancer therapy | |
| GB201409457D0 (en) | Molecules for cancer therapy | |
| GB201406529D0 (en) | Molecules for cancer therapy | |
| TH1501007353A (th) | สารประกอบชนิดใหม่สำหรับการบำบัดโรคมะเร็ง | |
| GB201414028D0 (en) | Small molecule inhibitors for cancer therapy | |
| GB201411884D0 (en) | Cancer therapy |